Earlier this week, I mentioned my reading of Three Billion New Capitalists by Clyde Prestowitz. I started reading this in part because I wanted to develop a better understanding of the benefits, challenges, and risks associated with this shift to the East.
Now, we hear a lot about GE and AMEX and Dell "outsourcing" manufacturing and services to India and China, but I don't see much written on how a small company, or better still, how a solo practitioner, can exploit this shift. How can I, as a consultant and adviser, working from my little home office, leverage this wealth of talent and capacity half a world away? What are the risks? What are the characteristics of the partnerships I would need to develop? And, most importantly, how can I (we) enable the emerging life science companies here in New York to tap into this wealth of talent and capacity, while at the same time creating companies and jobs here in New York?
I'll continue to study this issue, again, from the solo practitioner perspective, but I would be interested in hearing/reading your thoughts. Please post comments, or email/Skype/IM me. I will develop this line of thinking further in future postings, and perhaps even in an article somewhere.
This post was inspired, in part, by a recent post on Steve Shu's blog, regarding his very positive and productive collaboration with a fellow in India. Link.